Evidence map›Paper›PMID 31633894›Full record

ArticleThe New England journal of medicine2019

Neurodegenerative Disease Mortality among Former Professional Soccer Players.

Daniel F Mackay, Emma R Russell, Katy Stewart, John A MacLean, Jill P Pell, William Stewart

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The New England journal of medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 201 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
201citing papers in PubMed, 14 pooled it
35.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06736925 narecruitingnot on this mapstarted 2025, after this paper: background citation

Mechanistic Investigation of Omega-3 Fatty Acids Pretreatment Effects on Subconcussive Brain Injury

TypeinterventionalSponsorIndiana UniversityRan2025 to 2029Enrolled208ConditionsSubconcussive Head Impact, Omega-3 Fatty AcidsArmsOmega-3 Fatty Acids (EPA plus DHA), Organic soybean oil, Soccer Heading Model
NCT07010887 narecruitingnot on this mapstarted 2025, after this paper: background citation

Defining the Role of Repetitive Head Impact Time Intervals in Mitigating Subconcussive Neural Injury

TypeinterventionalSponsorIndiana UniversityRan2025 to 2028Enrolled102ConditionsRepetitive Head ImpactsArmsShort Interval, Long Interval, BrainScope qEEG
3 · Its place in the literature

Who cites it

201 citing papers in PubMed, 14 syntheses or guidelines pooled it, 464 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Neurodegenerative Disease and Association Football (NDAF): Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Neurophysiological Effects of Repeated Soccer Heading in Youth.Journal of biomechanical engineering · 2023
    Trial
  17. Trial
  18. Article
  19. Article
  20. Article

141 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniel F MackayFrom the Institute of Health and Wellbeing (D.F.M., J.P.P.), the Institute of Neuroscience and Psychology (E.R.R., W.S.), and the Institute of Cardiovascular and Medical Sciences (K.S., J.A.M.), University of Glasgow, the Hampden Sports Clinic, Hampden Stadium (K.S., J.A.M.), and the Department of Neuropathology, Queen Elizabeth University Hospital (W.S.) - all in Glasgow, United Kingdom.
Emma R RussellFrom the Institute of Health and Wellbeing (D.F.M., J.P.P.), the Institute of Neuroscience and Psychology (E.R.R., W.S.), and the Institute of Cardiovascular and Medical Sciences (K.S., J.A.M.), University of Glasgow, the Hampden Sports Clinic, Hampden Stadium (K.S., J.A.M.), and the Department of Neuropathology, Queen Elizabeth University Hospital (W.S.) - all in Glasgow, United Kingdom.
Katy StewartFrom the Institute of Health and Wellbeing (D.F.M., J.P.P.), the Institute of Neuroscience and Psychology (E.R.R., W.S.), and the Institute of Cardiovascular and Medical Sciences (K.S., J.A.M.), University of Glasgow, the Hampden Sports Clinic, Hampden Stadium (K.S., J.A.M.), and the Department of Neuropathology, Queen Elizabeth University Hospital (W.S.) - all in Glasgow, United Kingdom.
John A MacLeanFrom the Institute of Health and Wellbeing (D.F.M., J.P.P.), the Institute of Neuroscience and Psychology (E.R.R., W.S.), and the Institute of Cardiovascular and Medical Sciences (K.S., J.A.M.), University of Glasgow, the Hampden Sports Clinic, Hampden Stadium (K.S., J.A.M.), and the Department of Neuropathology, Queen Elizabeth University Hospital (W.S.) - all in Glasgow, United Kingdom.
Jill P PellFrom the Institute of Health and Wellbeing (D.F.M., J.P.P.), the Institute of Neuroscience and Psychology (E.R.R., W.S.), and the Institute of Cardiovascular and Medical Sciences (K.S., J.A.M.), University of Glasgow, the Hampden Sports Clinic, Hampden Stadium (K.S., J.A.M.), and the Department of Neuropathology, Queen Elizabeth University Hospital (W.S.) - all in Glasgow, United Kingdom.
William StewartFrom the Institute of Health and Wellbeing (D.F.M., J.P.P.), the Institute of Neuroscience and Psychology (E.R.R., W.S.), and the Institute of Cardiovascular and Medical Sciences (K.S., J.A.M.), University of Glasgow, the Hampden Sports Clinic, Hampden Stadium (K.S., J.A.M.), and the Department of Neuropathology, Queen Elizabeth University Hospital (W.S.) - all in Glasgow, United Kingdom.ORCID 0000-0003-2199-2582
University of Glasgow · GBQueen Elizabeth University Hospital · GB

Funding

Neuropathological Characterization of 'CTE'R01NS094003 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Douglas Hamilton Smith, William Stewart · 2016 to 2026
$5.1M
NINDS NIH HHS R01 NS094003United States NA
6 · The paper itself

Abstract

backgroundNeurodegenerative disorders have been reported in elite athletes who participated in contact sports. The incidence of neurodegenerative disease among former professional soccer players has not been well characterized.

methodsWe conducted a retrospective cohort study to compare mortality from neurodegenerative disease among 7676 former professional soccer players (identified from databases of Scottish players) with that among 23,028 controls from the general population who were matched to the players on the basis of sex, age, and degree of social deprivation. Causes of death were determined from death certificates. Data on medications dispensed for the treatment of dementia in the two cohorts were also compared. Prescription information was obtained from the national Prescribing Information System.

resultsOver a median of 18 years, 1180 former soccer players (15.4%) and 3807 controls (16.5%) died. All-cause mortality was lower among former players than among controls up to the age of 70 years and was higher thereafter. Mortality from ischemic heart disease was lower among former players than among controls (hazard ratio, 0.80; 95% confidence interval [CI], 0.66 to 0.97; P = 0.02), as was mortality from lung cancer (hazard ratio, 0.53; 95% CI, 0.40 to 0.70; P<0.001). Mortality with neurodegenerative disease listed as the primary cause was 1.7% among former soccer players and 0.5% among controls (subhazard ratio [the hazard ratio adjusted for competing risks of death from ischemic heart disease and death from any cancer], 3.45; 95% CI, 2.11 to 5.62; P<0.001). Among former players, mortality with neurodegenerative disease listed as the primary or a contributory cause on the death certificate varied according to disease subtype and was highest among those with Alzheimer's disease (hazard ratio [former players vs. controls], 5.07; 95% CI, 2.92 to 8.82; P<0.001) and lowest among those with Parkinson's disease (hazard ratio, 2.15; 95% CI, 1.17 to 3.96; P = 0.01). Dementia-related medications were prescribed more frequently to former players than to controls (odds ratio, 4.90; 95% CI, 3.81 to 6.31; P<0.001). Mortality with neurodegenerative disease listed as the primary or a contributory cause did not differ significantly between goalkeepers and outfield players (hazard ratio, 0.73; 95% CI, 0.43 to 1.24; P = 0.24), but dementia-related medications were prescribed less frequently to goalkeepers (odds ratio, 0.41; 95% CI, 0.19 to 0.89; P = 0.02).

conclusionsIn this retrospective epidemiologic analysis, mortality from neurodegenerative disease was higher and mortality from other common diseases lower among former Scottish professional soccer players than among matched controls. Dementia-related medications were prescribed more frequently to former players than to controls. These observations need to be confirmed in prospective matched-cohort studies. (Funded by the Football Association and Professional Footballers' Association.).

Indexed as

AthletesSoccerAdultAgedAged, 80 and overBrain InjuriesCase-Control StudiesCause of DeathFemaleHeart DiseasesHumansIncidenceLogistic ModelsLongevityLung NeoplasmsMaleNootropic Agents

Identifiers

PMID31633894
PMCPMC8747032
OpenAlexW2980770587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.